AbbVie
ABBV
#28
Rank
$279.17 B
Marketcap
$158.25
Share price
0.45%
Change (1 day)
-2.30%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 month history

Number of shares, 3 month chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2023$10.2 M-98.38%
2022$0.62 B629.28%
2021$86.13 M-77.97%
2020$0.39 B85.64%
2019$0.21 B-52.97%
2018$0.44 B269.88%
2017$0.12 B-48.45%
2016$0.23 B-37.53%
2015$0.37 B-44.13%
2014$0.67 B2387.79%
2013$27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3months) FTD volume (1 year) Country
$0.23 B$0.56 B๐Ÿ‡บ๐Ÿ‡ธ USA
$42.87 M$0.29 B๐Ÿ‡บ๐Ÿ‡ธ USA
$81.07 M$0.51 B๐Ÿ‡บ๐Ÿ‡ธ USA
$8.79 M$65.55 M๐Ÿ‡บ๐Ÿ‡ธ USA
$33.96 M$0.28 B๐Ÿ‡บ๐Ÿ‡ธ USA
$63.47 M$0.22 B๐Ÿ‡บ๐Ÿ‡ธ USA
$0.11 B$0.25 B๐Ÿ‡ฌ๐Ÿ‡ง UK
$27.64 M$72.38 M๐Ÿ‡ฌ๐Ÿ‡ง UK
$5.42 M$27.48 M๐Ÿ‡บ๐Ÿ‡ธ USA